RNK Health Tirzepatide Review: Cost, the Longevity Stack & Honest Verdict (2026)

RNK Health sells compounded tirzepatide alongside a genuine longevity stack — NAD+ in three delivery formats, sermorelin, enclomiphene, and a DNA biomarker panel — all from one account. Its entry pricing is published plainly on the public site rather than gated, a real transparency advantage over many competitors. This review's live check of myrnk.com returned an blocked (bot-protection) response, so the figures below rest on prior research rather than an independent reconfirmation this check. Every fact here comes from the company's own published program.

What RNK Health is

RNK Health is a GLP-1 and longevity telehealth platform, selling compounded tirzepatide alongside injectable and oral compounded semaglutide, NAD+, sermorelin, enclomiphene, and a DNA biomarker panel. This review's live attempt to independently verify the site returned a security-challenge response, consistent with active bot-detection rather than a defunct site — the figures here reflect prior research, not our own check.

What RNK Health costs

Entry pricing is published plainly rather than gated — tirzepatide from $297/month, injectable semaglutide $197/month, oral semaglutide $198/month, all-inclusive. That level of openness is more than many competitors manage. Anything beyond the entry tier, including multi-month pricing, reportedly requires the intake quiz. Confirm current figures directly with RNK Health, since this review's own live pass was blocked from independently reconfirming them.

The brand-vs-compounded question

RNK Health dispenses compounded tirzepatide only — no route to FDA-approved Zepbound or Mounjaro. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

RNK Health's real strengths: entry pricing published openly on the public site rather than gated behind a quiz, a genuine longevity stack (NAD+, sermorelin, enclomiphene, DNA panel) if you want more than a GLP-1 from one provider, and both injectable and oral compounded semaglutide where most programs carry only one. The trade-offs: at $297/month, tirzepatide sits above the median for compounded programs in this category, and multi-month pricing isn't published before the quiz; states served are not listed anywhere on the public site; the pharmacy partner is not named beyond a Springville, Utah fulfillment reference; and the very broad catalog for what appears to be a small platform raises a fair question about clinical depth on any one line. As with any GLP-1 program, confirm state coverage directly before starting an intake; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

RNK Health is worth considering if you want GLP-1 treatment bundled with a genuine longevity catalog from one provider, and its openly-published entry pricing is a real, checkable positive — but the unnamed states-served list and pharmacy partner are gaps worth weighing. If you want a lower published entry price and a named pharmacy, compare it against bmiMD. See our best tirzepatide providers ranking for the full field.